anonymous
Guest
anonymous
Guest
Bad: topicals are hard to price to make money/generic world, no derm heritage, low salaries, hard to launch anything with Covid restrictions
Good: good takeover candidate so get your equity up there, small company that hasn't been infected with Amgen, Novartis, Abbie types yet - so the first couple years you will be invented to sell/earn. After that, look for big Pharma bone heads to infiltrate and implement selling models, coaching guides, all the BS that kills culture but grows activity
Infected by AZ is better? Cmon man!